GMO Research & AI, Inc. Logo

GMO Research & AI, Inc.

Market research tech providing access to 65M+ APAC consumer panelists for data-driven insights.

3695 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
渋谷区桜丘町26番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

GMO Research & AI, Inc. is a market research technology company specializing in the Asia-Pacific region. Through its Asia Cloud Panel, an online audience engagement platform, the company provides access to over 65 million consumer panelists across 14 APAC markets. As Japan's leading consumer panel provider, GMO Research & AI offers comprehensive sampling solutions for consumer, B2B, and healthcare sectors. The firm leverages deep regional, cultural, and linguistic expertise to deliver reliable, localized data and actionable insights, enabling global clients to make informed, data-driven decisions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 04:59
Report Publication Announcement
確認書
Japanese 9.0 KB
2025-08-13 04:57
Interim Report
半期報告書-第24期(2025/01/01-2025/12/31)
Japanese 254.0 KB
2025-05-19 09:11
Registration Form
臨時報告書
Japanese 35.5 KB
2025-03-19 05:04
Regulatory News Service
臨時報告書
Japanese 29.4 KB
2025-03-19 03:13
Regulatory News Service
確認書
Japanese 9.4 KB
2025-03-19 03:11
Regulatory News Service
内部統制報告書-第23期(2024/01/01-2024/12/31)
Japanese 24.8 KB
2025-03-19 03:09
Annual Report
有価証券報告書-第23期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2025-02-12 07:40
Regulatory News Service
臨時報告書
Japanese 173.9 KB
2024-08-09 06:15
Regulatory News Service
確認書
Japanese 9.4 KB
2024-08-09 06:14
Interim Report
半期報告書-第23期(2024/01/01-2024/12/31)
Japanese 203.1 KB
2024-05-13 04:45
Regulatory News Service
確認書
Japanese 9.5 KB
2024-05-13 04:45
Quarterly Report
四半期報告書-第23期第1四半期(2024/01/01-2024/03/31)
Japanese 160.7 KB
2024-03-19 03:42
Registration Form
確認書
Japanese 8.9 KB
2024-03-19 03:39
Governance Information
内部統制報告書-第22期(2023/01/01-2023/12/31)
Japanese 24.0 KB
2024-03-19 03:37
Registration Form
有価証券報告書-第22期(2023/01/01-2023/12/31)
Japanese 1.3 MB

Automate Your Workflow. Get a real-time feed of all GMO Research & AI, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for GMO Research & AI, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.